[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538474":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":53,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"NIPP treatment",null,"Treatment with cold physical Plasma",[13],"Other: Cold physical Plasma",{"label":15,"type":10,"description":16,"interventionNames":17},"Control group","No treatment with cold physical Plasma",[18],"Other: Control group",[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Cold physical Plasma","The treatment is administered by either the supervising specialists or assistant doctors at the University Women's Hospital, under their supervision and authorization. It's important to note that the NIPP treatment is designed to be relatively brief, with a duration not exceeding 10-20 minutes.",[9],{"type":6,"name":15,"description":25,"armGroupLabels":26,"otherNames":10},"A potential natural healing of the HPV infection will be anticipated",[15],[28],{"name":29,"affiliation":5,"role":30},"Martin Weiss, Dr. med.","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":35},"CONTACT","+497071 29 82211","martin.weiss@med.uni-tuebingen.de",[37],{"facility":38,"status":39,"city":40,"state":10,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"University Hospital Tuebingen, Department of Women's Health","RECRUITING","Tübingen","72076","Germany","DE",{"type":45,"coordinates":46},"Point",[47,48],9.05222,48.52266,{"lat":48,"lon":47},[51],{"name":29,"role":33,"phone":52,"phoneExt":10,"email":35},"+4970712982211",{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100538474","non-invasive-plasma-treatment-for-cervical-infections-targeting-high--and-low-risk-hpv-variants-100538474",false,"NCT06291311","Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants","Treatment of Infections of the Cervix Uteri With High- and Low-risk Variants of the Human Papillomavirus Using Non-invasive Physical Plasma","Inclusion Criteria:\n\n* Inclusion criteria for NIPP treatment\n\n  * Age ≥ 18 years\n  * mRNA or DNA-based virus detection by smear (also external findings)\n  * Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1\u002FT2\n  * Written informed consent to participate in the study\n* Inclusion criteria for control group\n\n  * Age ≥ 18 years\n  * Swab-based mRNA or DNA-based virus detection (also external findings)\n  * Clearly visible transformation zone of the cervix corresponding to T1\u002FT2\n  * Written informed consent to participate in the study\n\nExclusion criteria:\n\nThe following exclusion criteria apply to both groups of patients (NIPP treatment and control group).\n\n* Transformation zone not fully visible\n* Evidence of invasive disease\n* Serious cardiovascular diseases","FEMALE","18 Years",{"count":65,"type":66},50,"ESTIMATED","OBSERVATIONAL","This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.",[70,71],"HPV Infection","Cervical Cancer","2026-06-25",{"date":74,"type":75},"2026-06-30","ACTUAL",{"date":77,"type":75},"2023-12-27",{"date":79,"type":66},"2026-12",{"name":5,"class":6},1]